NCT04075214View on ClinicalTrials.gov

Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Opioid-use DisorderOpioid Withdrawal
Interventions
DEVICE

transcutaneous auricular neurostimulation (tAN)

Phoenix tAN system

Trial Locations (1)

78745

Recovery Unplugged, Austin

All Listed Sponsors
lead

Spark Biomedical, Inc.

INDUSTRY

NCT04075214 - Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal | Biotech Hunter | Biotech Hunter